Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis

被引:94
作者
Li, Jie [1 ,2 ]
Fadare, Oluwole [3 ]
Xiang, Li [1 ,2 ]
Kong, Beihua [1 ,2 ]
Zheng, Wenxin [1 ,2 ,4 ,5 ]
机构
[1] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan 250012, Shandong, Peoples R China
[2] Univ Arizona, Dept Pathol, Coll Med, Tucson, AZ 85724 USA
[3] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA
[4] Univ Arizona, Dept Obstet & Gynecol, Tucson, AZ USA
[5] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA
关键词
Ovarian cancer; Fallopian tube; Carcinogenesis; Serous carcinoma; p53; signatures; PROPHYLACTIC OOPHORECTOMY SPECIMENS; POTENTIAL BORDERLINE TUMORS; FALLOPIAN-TUBE EPITHELIUM; BRCA MUTATION CARRIERS; LOW-GRADE; INTRAEPITHELIAL CARCINOMA; MOLECULAR PATHOGENESIS; SALPINGO-OOPHORECTOMY; PATHOLOGICAL FINDINGS; CANDIDATE PRECURSOR;
D O I
10.1186/1756-8722-5-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recent morphologic and molecular genetic studies have led to a paradigm shift in our conceptualization of the carcinogenesis and histogenesis of pelvic (non-uterine) serous carcinomas. It appears that both low-grade and high-grade pelvic serous carcinomas that have traditionally been classified as ovarian in origin, actually originate, at least in a significant subset, from the distal fallopian tube. Clonal expansions of the tubal secretory cell probably give rise to serous carcinomas, and the degree of ciliated conversion is a function of the degree to which the genetic hits deregulate normal differentiation. In this article, the authors review the evidentiary basis for aforementioned paradigm shift, as well as its potential clinical implications.
引用
收藏
页数:11
相关论文
共 88 条
[61]   Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer [J].
Piek, JMJ ;
van Diest, PJ ;
Zweemer, RP ;
Jansen, JW ;
Poort-Keesom, RJJ ;
Menko, FH ;
Gille, JJP ;
Jongsma, APM ;
Pals, G ;
Kenemans, P ;
Verheijen, RHM .
JOURNAL OF PATHOLOGY, 2001, 195 (04) :451-456
[62]  
Piek JMJ, 2001, LANCET, V358, P844, DOI 10.1016/S0140-6736(01)05992-X
[63]   Genetic Analysis of the Early Natural History of Epithelial Ovarian Carcinoma [J].
Pothuri, Bhavana ;
Leitao, Mario M. ;
Levine, Douglas A. ;
Viale, Agnes ;
Olshen, Adam B. ;
Arroyo, Crispinita ;
Bogomolniy, Faina ;
Olvera, Narciso ;
Lin, Oscar ;
Soslow, Robert A. ;
Robson, Mark E. ;
Offit, Kenneth ;
Barakat, Richard R. ;
Boyd, Jeff .
PLOS ONE, 2010, 5 (04)
[64]   Risk-reducing salpingo-oophorectomy in BRCA mutation carriers:: Role of serial sectioning in the detection of occult malignancy [J].
Powell, CB ;
Kenley, E ;
Chen, LM ;
Crawford, B ;
McLennan, J ;
Zaloudek, C ;
Komaromy, M ;
Beattie, M ;
Ziegler, J .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (01) :127-132
[65]   Are All Pelvic (Nonuterine) Serous Carcinomas of Tubal Origin? [J].
Przybycin, Christopher G. ;
Kurman, Robert J. ;
Ronnett, Brigitte M. ;
Shih, Ie-Ming ;
Vang, Russell .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2010, 34 (10) :1407-1416
[66]  
Quick CM, 2011, MODERN PATHOL, V25, P455
[67]   Tumorigenesis -: RAF/RAS oncogenes and mismatch-repair status [J].
Rajagopalan, H ;
Bardelli, A ;
Lengauer, C ;
Kinzler, KW ;
Vogelstein, B ;
Velculescu, VE .
NATURE, 2002, 418 (6901) :934-934
[68]  
Ries L., 2007, SEER CANC STAT REV 1
[69]   Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: A kin-cohort study in Ontario, Canada [J].
Risch, Harvey A. ;
McLaughlin, John R. ;
Cole, David E. C. ;
Rosen, Barry ;
Bradley, Linda ;
Fan, Isabel ;
Tang, James ;
Li, Song ;
Zhang, Shiyu ;
Shaw, Patricia A. ;
Narod, Steven A. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (23) :1694-1706
[70]   Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance [J].
Salani, R. ;
Kurman, R. J. ;
Giuntoli, R., II ;
Gardner, G. ;
Bristow, R. ;
Wang, T. -L. ;
Shih, I. -M. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (03) :487-491